Quick Takeaways
- John Johnson has 5 issuer positions tracked on this page.
- Estimated disclosed ownership value: $8,068,722.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of John Johnson
- Location
- Seattle, WA
- Summary
- The estimated net worth of John Johnson is at least $8,068,722 dollars as of 19 Dec 2025. John Johnson is the Director of Xeris Biopharma Holdings, Inc. and owns shares of Xeris Biopharma Holdings, Inc. (XERS) stock worth about $5.04M. John Johnson is the Executive Chairman, Director of Applied Therapeutics, Inc. and owns shares of Applied Therapeutics, Inc. (APLT) stock worth about $2.92M. John Johnson is the Director of Verastem, Inc. and owns shares of Verastem, Inc. (VSTM) stock worth about $116.5K.
- Signature
- /s/ Beth Hecht, Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow John Johnson and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: Xeris Biopharma Holdings, Inc. ($5,037,227).
- Past-year value change for that position: -$1,763,479.
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of John Johnson
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| XERS | Xeris Biopharma Holdings, Inc. | Director | $5,037,227 | -$1,763,479 | -26% | 19 Dec 2025 |
| APLT | Applied Therapeutics, Inc. | Executive Chairman, Director | $2,915,000 | 19 Dec 2024 | ||
| VSTM | Verastem, Inc. | Director | $116,495 | 22 May 2025 | ||
| AXGN | Axogen, Inc. | Director | $0 | -$1,433,607 | -100% | 08 Dec 2025 |
| SBBP | Strongbridge Biopharma plc | Chief Executive Officer, Director | 05 Oct 2021 |
Insider Transactions Reported by John Johnson:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.